Stock Market News 2021-04-10

58 news published.

2021-04-09 2021-04-11

IMPACT

SENTIMENT

04/10/2021 11:25 PM

WWE : NYSE

Saturday WrestleMania® Sold Out

IMPACT

SENTIMENT

04/10/2021 05:05 PM

GTII : OTC

GLOBAL TECH INDUSTRIES GROUP, INC. SIGNS LETTER OF INTENT WITH ALT 5 SIGMA, INC. TO EXPLORE BUSINESS COMBINATION

IMPACT

SENTIMENT

04/10/2021 04:13 PM

GLSI : Nasdaq

Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer

IMPACT

SENTIMENT

04/10/2021 03:45 PM

BABYF : OTC

Else Nutrition Issues Shares for Services

IMPACT

SENTIMENT

04/10/2021 03:05 PM

CCCC : Nasdaq

C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 02:35 PM

MRTX : Nasdaq

Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models

IMPACT

SENTIMENT

04/10/2021 02:20 PM

IRTC : Nasdaq

iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication

IMPACT

SENTIMENT

04/10/2021 02:15 PM

PIRS : NASDAQ

Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Meeting

IMPACT

SENTIMENT

04/10/2021 01:31 PM

PMVP : Nasdaq

PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 01:31 PM

OCX : Nasdaq

Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™

IMPACT

SENTIMENT

04/10/2021 01:30 PM

ZNTL : Nasdaq

Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors

IMPACT

SENTIMENT

04/10/2021 10:02 AM

THTX : Nasdaq

Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types

IMPACT

SENTIMENT

04/10/2021 09:37 AM

SYBX : Nasdaq

Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting

IMPACT

SENTIMENT

04/10/2021 09:33 AM

GRCL : Nasdaq

Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting

IMPACT

SENTIMENT

04/10/2021 09:22 AM

FSTX : Nasdaq

F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster

IMPACT

SENTIMENT

04/10/2021 09:00 AM

GLYC : Nasdaq

Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting

IMPACT

SENTIMENT

04/10/2021 09:00 AM

GLYC : Nasdaq

GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model

IMPACT

SENTIMENT

04/10/2021 09:00 AM

MRSN : Nasdaq

Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:35 AM

FUSN : Nasdaq

Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy in Multiple Preclinical Tumor Models

IMPACT

SENTIMENT

04/10/2021 08:35 AM

GH : Nasdaq

Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers

IMPACT

SENTIMENT

04/10/2021 08:35 AM

AGEN : Nasdaq

New Clinical Responses for AGEN1181 Presented at AACR

IMPACT

SENTIMENT

04/10/2021 08:33 AM

RCUS : NYSE

Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:31 AM

HOOK : Nasdaq

HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers

IMPACT

SENTIMENT

04/10/2021 08:31 AM

ADXS : Nasdaq

Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:31 AM

VINC : Nasdaq

Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:31 AM

JNCE : Nasdaq

Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:31 AM

CRSP : Nasdaq

CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function

IMPACT

SENTIMENT

04/10/2021 08:31 AM

TCRR : Nasdaq

TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

IMGN : Nasdaq

ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

CLVS : Nasdaq

Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

SRRK : Nasdaq

Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

SPPI : Nasdaq

Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

XNCR : Nasdaq

Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

SQZ : NYSE

SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BDSX : Nasdaq

Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BCYC : Nasdaq

Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

ZYME : NYSE

Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

KZR : Nasdaq

Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BMY : NYSE

Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial

IMPACT

SENTIMENT

04/10/2021 08:30 AM

EPIX : Nasdaq

ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BPMC : Nasdaq

Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

PHIO : Nasdaq

Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting PD-1

IMPACT

SENTIMENT

04/10/2021 08:30 AM

MEIP : Nasdaq

MEI Pharma Reports Preclinical Data Demonstrating Ability of Voruciclib to Regulate MYC and Synergize with KRAS Inhibitors in KRAS Mutant Cancers

IMPACT

SENTIMENT

04/10/2021 08:30 AM

CRDF : Nasdaq

Cardiff Oncology in Collaboration with MIT Presents Gene Signature Analyses Data Identifying Androgen-Independent Mechanism for Onvansertib-Abiraterone Synergy in mCRPC

IMPACT

SENTIMENT

04/10/2021 08:30 AM

CRDF : Nasdaq

Cardiff Oncology Presents Findings from its Expanded Access Program Highlighting the Clinical Benefit of Onvansertib in Heavily Pretreated Patients with Metastatic KRAS-Mutated mCRC

IMPACT

SENTIMENT

04/10/2021 08:30 AM

ACHL : Nasdaq

Achilles Therapeutics Demonstrates cNeT Product Characterization and Post-Infusion Tracking in a Patient Case Study at the American Association for Cancer Research (AACR) 2021 Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

KRON : Nasdaq

Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

ITOS : Nasdaq

iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

HARP : Nasdaq

Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

ALLO : Nasdaq

Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BOLT : Nasdaq

Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001

IMPACT

SENTIMENT

04/10/2021 08:30 AM

NXTC : Nasdaq

NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

GNCA : Nasdaq

Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

NCNA : Nasdaq

NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021

IMPACT

SENTIMENT

04/10/2021 08:30 AM

BDTX : Nasdaq

Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

MGNX : Nasdaq

MacroGenics Announces Presentations at the 2021 AACR Annual Meeting

IMPACT

SENTIMENT

04/10/2021 08:30 AM

CDAK : Nasdaq

Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated Cancer Immunotherapy Pathways

IMPACT

SENTIMENT

04/10/2021 08:30 AM

KYMR : Nasdaq

Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021

2021-04-09 2021-04-11